The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Bacteriophage Cocktail for the Prevention of Biofilm Formation by Pseudomonas aeruginosa on Catheters in an In Vitro Model System
Open accessAbstract
Microorganisms develop biofilms on indwelling medical devices and are associated with device-related infections, resulting in substantial morbidity and mortality. This study investigated the effect of pretreating hydrogel-coated catheters with Pseudomonas aeruginosa bacteriophages on biofilm formation by P. aeruginosa in an in vitro model. Hydrogel-coated catheters were exposed to a 10 log 10 PFU ml −1 lysate of P. aeruginosa phage M4 for 2 h at 37°C prior to bacterial inoculation. The mean viable biofilm count on untreated catheters was 6.87 log 10 CFU cm −2 after 24 h. The pretreatment of catheters with phage reduced this value to 4.03 log 10 CFU cm −2 ( P < 0.001). Phage treatment immediately following bacterial inoculation also reduced biofilm viable counts (4.37 log 10 CFU cm −2 reduction; P < 0.001). The regrowth of biofilms on phage-treated catheters occurred between 24 and 48 h, but supplemental treatment with phage at 24 h significantly reduced biofilm regrowth ( P < 0.001). Biofilm isolates resistant to phage M4 were recovered from catheters pretreated with phage. The phage susceptibility profiles of these isolates were used to guide the development of a five-phage cocktail from a larger library of P. aeruginosa phages. The pretreatment of catheters with this cocktail reduced the 48-h mean biofilm cell density by 99.9% (from 7.13 to 4.13 log 10 CFU cm −2 ; P < 0.001), but fewer biofilm isolates were resistant to these phages. These results suggest the potential of applying phages, especially phage cocktails, to the surfaces of indwelling medical devices for mitigating biofilm formation by clinically relevant bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Self-citationCRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00797.x · Cited by 2,537
Christensen, G. D., Simpson, W. A., Younger, J. J., Baddour, L. M., Barrett, F. F., Melton, D. M., & Beachey, E. H. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.22.6.996-1006.1985 · Cited by 2,255
Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
Drenkard, E., & Ausubel, F. M. (2002) · Nature · doi:10.1038/416740a · Cited by 997
Guideline for Hand Hygiene in Health-Care Settings
(2002) · PsycEXTRA Dataset · doi:10.1037/e548382006-001 · Cited by 941
Dispersing biofilms with engineered enzymatic bacteriophage
Lu, T. K., & Collins, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704624104 · Cited by 895
Molecular Biology of Bacteriophage T4
(1994) · ASM Press eBooks · doi:10.1128/ecosalplus.bacteriophage-t4 · Cited by 878
Cell Death in Pseudomonas aeruginosa Biofilm Development
Webb, J. S., Thompson, L. S., James, S., Charlton, T., Tolker-Nielsen, T., Koch, B., Givskov, M., & Kjelleberg, S. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.15.4585-4592.2003 · Cited by 599
Guideline for Prevention of Intravascular-Device-Related Infections
Pearson, M. L., & The Hospital Infection Control Practices Advisory Committee (1996) · Infection Control and Hospital Epidemiology · doi:10.2307/30141155 · Cited by 531
Lenski, R. E., & Levin, B. R. (1985) · The American Naturalist · doi:10.1086/284364 · Cited by 460
Déziel, E., Comeau, Y., & Villemur, R. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.4.1195-1204.2001 · Cited by 459
Rice, S. A., Tan, C. H., Mikkelsen, P. J., Kung, V., Woo, J., Tay, M., Hauser, A., McDougald, D., Webb, J. S., & Kjelleberg, S. (2009) · The ISME Journal · doi:10.1038/ismej.2008.109 · Cited by 380
Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase
Hughes, K. A., Sutherland, I. W., & Jones, M. V. (1998) · Microbiology · doi:10.1099/00221287-144-11-3039 · Cited by 360
Bacteriophage T4 Development Depends on the Physiology of its Host Escherichia Coli
Hadas, H., Einav, M., Fishov, I., & Zaritsky, A. (1997) · Microbiology · doi:10.1099/00221287-143-1-179 · Cited by 354
Preventing biofilms of clinically relevant organisms using bacteriophage
Donlan, R. M. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.11.002 · Cited by 345
Self-citationBarrow, P., Lovell, M., & Berchieri, A. (1998) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.5.3.294-298.1998 · Cited by 293
Bacteriophage and Phenotypic Variation in Pseudomonas aeruginosa Biofilm Development
Webb, J. S., Lau, M., & Kjelleberg, S. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.23.8066-8073.2004 · Cited by 287
Curtin, J. J., & Donlan, R. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1268-1275.2006 · Cited by 276
Self-citationHanlon, G. W., Denyer, S. P., Olliff, C. J., & Ibrahim, L. J. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.6.2746-2753.2001 · Cited by 244
O’Flaherty, S., Ross, R. P., Meaney, W. J., Fitzgerald, G. F., Elbreki, M., & Coffey, A. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.4.1836-1842.2005 · Cited by 243
Markoishvili, K., Tsitlanadze, G., Katsarava, R., Glenn, J., Morris Jr., M. D., & Sulakvelidze, A. (2002) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2002.01451.x · Cited by 243
Small-Colony Variants of Pseudomonas aeruginosa in Cystic Fibrosis
Rohde, M. (1999) · Clinical Infectious Diseases · doi:10.1086/598644 · Cited by 238
Dynamics of Interactions between Bacteria and Virulent Bacteriophage
Lenski, R. E. (1988) · Advances in Microbial Ecology · doi:10.1007/978-1-4684-5409-3_1 · Cited by 235
Deretic, V, Schurr, M. J., Boucher, J. C., & Martin, D. W. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.10.2773-2780.1994 · Cited by 213
Antibiotics and prevention of microbial colonization of catheters
Raad, I., Darouiche, R., Hachem, R., Sacilowski, M., & Bodey, G. P. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2397 · Cited by 211
Bacteriophage Therapy of Bacterial Infections: An Update of our Institute’s Experience
Weber-Dąbrowska, B., Mulczyk, M., & Górski, A. (2001) · Inflammation · doi:10.1007/978-94-015-9702-9_15 · Cited by 199
Bacteriophage Therapy in Humans
Sulakvelidze, A., & Kutter, E. (2004) · Bacteriophages · doi:10.1201/9780203491751.ch14 · Cited by 170
Working with bacteriophages: common techniques and methodological approaches
Carlson, K. (2005) · Cited by 160
Doolittle, M. M., Cooney, J. J., & Caldwell, D. E. (1996) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/bf01570111 · Cited by 140
Lytic infection ofEscherichia colibiofilms by bacteriophage T4
Doolittle, M. M., Cooney, J. J., & Caldwell, D. E. (1995) · Canadian Journal of Microbiology · doi:10.1139/m95-002 · Cited by 138
Ahearn, D. G., Grace, D. T., Jennings, M. J., Borazjani, R. N., Boles, K. J., Rose, L. J., Simmons, R. B., & Ahanotu, E. N. (2000) · Current Microbiology · doi:10.1007/s002840010105 · Cited by 136
Guttman, B. S., Raya, R. R., & Kutter, E. M. (2004) · CRC Press eBooks · doi:10.1201/9780203491751.ch3 · Cited by 135
Bacteriophage Φ S1 Infection of Pseudomonas fluorescens Planktonic Cells versus Biofilms
Sillankorva, S., Oliveira, R., Vieira, M. J., Sutherland, I., & Azeredo, J. (2004) · Biofouling · doi:10.1080/08927010410001723834 · Cited by 134
Cerca, N., de Oliveira, R. P. S., & Azeredo, J. (2007) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2007.02190.x · Cited by 133
Phage Resistance Mechanisms in Lactic Acid Bacteria
Allison, G. E., & Klaenhammer, T. R. (1998) · International Dairy Journal · doi:10.1016/s0958-6946(98)00043-0 · Cited by 131
Bacteriophage T4 multiplication in a glucose-limited Escherichia coli biofilm
Corbin, B. D., McLean, R. J. C., & Aron, G. M. (2001) · Canadian Journal of Microbiology · doi:10.1139/cjm-47-7-680 · Cited by 72
Mooij, M. J., Drenkard, E., Llamas, M. A., Vandenbroucke‐Grauls, C. M. J. E., Savelkoul, P. H. M., Ausubel, F. M., & Bitter, W. (2007) · Microbiology · doi:10.1099/mic.0.2006/003533-0 · Cited by 60
Bacteriophage T4 multiplication in a glucose-limited Escherichia coli biofilm
Corbin, B. D., McLean, R. J. C., & Aron, G. M. (2001) · Canadian Journal of Microbiology · doi:10.1139/w01-059 · Cited by 51
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
Phage Cocktails and the Future of Phage Therapy
Chan, B. K., Abedon, S. T., & Loc-Carrillo, C. (2013) · Future Microbiology · doi:10.2217/fmb.13.47 · Cited by 914
Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance
Uruén, C., Chopo-Escuin, G., Tommassen, J., Mainar-Jaime, R. C., & Arenas, J. (2020) · Antibiotics · doi:10.3390/antibiotics10010003 · Cited by 769
Polymicrobial Interactions: Impact on Pathogenesis and Human Disease
Peters, B. M., Jabra-Rizk, M. A., O'May, G. A., Costerton, J. W., & Shirtliff, M. E. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00013-11 · Cited by 712
Metadata
- Authors
- Fu, W., Forster, T., Mayer, O., Curtin, J. J., Lehman, S. M., & Donlan, R. M.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2010-01
- Volume
- 54
- Issue
- 1
- Pages
- 397-404
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2114933813
- Cited by
- 362
- References
- 41
- FWCI
- 13.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.